InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: None

Saturday, 06/19/2021 6:33:57 PM

Saturday, June 19, 2021 6:33:57 PM

Post# of 140474
Just to provide some clarifications...

According to another poster, one third of 165 is 12. 12 patents were licensed, which is one third of Titan's patent portfolio. So 12 is one third of 165, if you believe their math.

Also, nobody else has any interest in this technology. So the multiple board meetings which were held by Titan while excluding the Medtronic monitor from those meetings were for... I dunno. If it wasn't to discuss other possible "partners" then I just don't know what they were talking about. Butnthats just me, I apparently have no imagination.

As I keep encouraging others to ask Titan questions. I asked about board meetings which were held with MDT representation excluded. There were more than one such board meeting. Why? Go ahead Honeycomb and answer that one. What were they talking about? Looking at the requirements for Titan to exclude MDT, it was something that either violated attorney confidentiality or was a conflict of interest between the two organizations. They wouldn't tell me why MDT was excluded but it happened more than once. Please explain!

And as always, feel free to confirm for yourself. I will continue to request people get their own info instead of believing all the misinformation offered here by others.